News | January 22, 2022
USFDA expands use of Remdesivir for Covid-19
Previously, the use of the drug was limited to patients requiring hospitalization
Previously, the use of the drug was limited to patients requiring hospitalization
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
This test analyses samples in VTM directly without the need for RNA extraction step
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Subscribe To Our Newsletter & Stay Updated
